progress into bronchiolitis obliterans (BO) in children. 2 There are also reports of M. pneumoniae bronchiolitisassociated restrictive BO in adults. [3] [4] [5] Because BO has a major influence on a child's quality of life and is associated with M. pneumoniae bronchiolitis, early identification and treatment of M. pneumoniae bronchiolitis is important to prevent the development of BO. To this end, we herein report eight cases of M. pneumoniae bronchiolitis in children to enhance the understanding of this disorder.
MeTHODs

Patients
Eight patients diagnosed with M. pneumoniae bronchiolitis from February 2016 to July 2017 were included in this study. The diagnosis of M. pneumoniae bronchiolitis was based on high-resolution computed tomography (HRCT) findings, including centrilobular nodules, branching linear opacities (tree-in-bud pattern), and bronchiolar wall thickening; 6 a serum IgM-specific anti-Mycoplasma antibody titer of ≥ 1:160 in the acute phase or a four-fold rise during convalescence; and negative bacterial cultures of the blood, sputum, and/or bronchoalveolar lavage fluid were also suggestive of bronchiolitis.
Data collection
This was an observational and descriptive study. The medical records of all patients were retrospectively r e v i e w e d . We c o l l e c t e d d a t a o n d e m o g r a p h i c characteristics, clinical presentations, physical examination findings, chest HRCT findings, atopic data, and treatment. We also gathered follow-up information on all patients. The data of all eight patients are shown in Table 1 .
Clinical definition
An atopic background was defined as one of three findings: positive personal and/or family history of atopic disease, allergy to airborne allergens, or a history of atopic disease.
resUlTs
Demographic characteristics
The eight patients in this study ranged in age from 3 years 10 months to 8 years 9 months (mean age: 6 years 1 month). Five patients were male and three were female.
Clinical features
All patients had a fever and cough for 3 to 14 days. Three patients had wheezing for 2 to 14 days. Moist rales and wheezing were noted in six patients.
Radiologic findings
Chest HRCT findings included centrilobular nodules, branching linear opacities (tree-in-bud pattern), and bronchiolar wall thickening (unilateral distribution in two patients [ Figure 1 ] and bilateral distribution in six patients [ Figure 2] ). Focal bronchopneumonia was observed in six patients, and bronchial wall thickening and mucus plugs in two.
Co-existing asthma and atopic background
Two patients had asthma and two had allergic rhinitis before the onset of bronchiolitis. Seven patients had a personal and/or family history of atopic disease. Allergen testing was conducted in six patients, whereby four had positive results and two had negative results, although their total IgE levels were > 200 IU/ml.
Treatment
All patients received azithromycin at a dose of 10 mg/kg/ day for 5 days; this dose was repeated once more after an interval of 3 days. Six patients began treatment with 1 to 2 mg/kg/day of methylprednisolone on days 4, 9, 10, and 11 after the onset of illness, respectively. The total course ranged from 8 to 15 days in these patients. The remaining two patients (Patients 5 and 8) received a glucocorticoid via inhalation. One patient (Patient 1) developed respiratory failure and was given nasal continuous positive airway pressure ventilation. The remaining seven patients did not require supplemental oxygen therapy.
Follow-up
All patients were followed up for 4 to 8 months. All were asymptomatic and had normal lung function and chest X-rays at follow-up.
DIsCUssION
We have herein reported the clinical features of childhood M. pneumoniae bronchiolitis. Although six patients had bronchopneumonia and two had large airway injury, the prominent findings on chest HRCT in all patients were in accordance with bronchiolitis (Figures 1 and 2) . Furthermore, all patients had evidence of M. pneumoniae infection. Therefore, the diagnosis of M. pneumoniae bronchiolitis was confirmed.
To the best of our knowledge, seven case reports and one case series of M. pneumoniae bronchiolitis have been published to date in the English-language literature, 1, 3-5, 7-10 comprising nine adult cases and one pediatric case. In addition, Cha et al 11 described 29 adult patients with M. pneumoniae infection, of whom eight had bronchiolitis (28%) and 21 had pneumonia. We conclude from these reports and our study that M. pneumoniae can cause bronchiolitis.
Why did M. pneumoniae infection cause bronchiolitis rather than airspace consolidation in these individuals? Tanaka 12 found that the type of M. pneumoniae infection might be associated with host factors: in their study, upregulation of host cell-mediated immunity predominantly caused centrilobular nodules, whereas downregulation of host cell-mediated immunity changed the radiological pattern to consolidation. We propose that M. pneumoniae bronchiolitis might be associated with an atopic constitution because all patients in this study had atopic backgrounds. Vasudevan et al 7 reported that an adult with severe M. pneumoniae bronchiolitis had a history of asthma; moreover, Kawamoto et al 8 found elevated levels of eosinophil cationic protein and IgE in two patients with M. pneumoniae bronchiolitis, further supporting the hypothesis that atopy may be associated with the occurrence of M. pneumoniae bronchiolitis.
Our previous study 2 and other reports [3] [4] [5] have shown that BO can develop following acute M. pneumoniae bronchiolitis. Because BO is a chronic airway obstruction disease and is irreversible, it is important to prevent the development of BO after acute M. pneumoniae bronchiolitis.
BO is caused by granulation tissue obstruction, and glucocorticoids can inhibit the formation of granulation tissue. In our previous study, 17 patients with acute M. pneumoniae bronchiolitis developed BO soon after acute M. pneumoniae bronchiolitis, and only 10 (59%) of them received systemic glucocorticoid therapy.
2 Therefore, we speculate that glucocorticoids might have a beneficial effect on preventing the development of BO after acute M. pneumoniae bronchiolitis. Additionally, because the features of BO on HRCT, such as pronounced air-trapping and a mosaic pattern, were noted within 2 to 3 weeks following the onset of bronchiolitis, 2 we surmise that initiation of glucocorticoids within 2 weeks might play a preventive role. However, the appropriate time window for starting glucocorticoids and for how long they may be used require further study.
To explore the effect of glucocorticoid therapy on preventing the development of BO after acute M. pneumoniae bronchiolitis, we treated six patients (75%) in this study with 1 to 2 mg/kg/day of methylprednisolone after admission at 9.2 ± 2.3 days after onset of acute M. pneumoniae bronchiolitis, as shown in Table 1 . Compared with the 10 patients who developed BO and received 1 to 2 mg/kg/day of methylprednisolone at 12.2 ± 3.5 days as reported in our previous study, 2 the time of glucocorticoid initiation in these six patients was 3 days earlier (9.2 ± 2.3 versus 12.2 ± 3.5 days). The remaining two mildly affected patients received a glucocorticoid via inhalation. The fact that none of our eight patients developed BO supports the notion that earlier initiation of glucocorticoid therapy might favor the prognosis of acute M. pneumoniae bronchiolitis. This study has some limitations. Because acute bronchiolitis caused by M. pneumoniae is rare, the patient sample was too small to support a definitive conclusion. However, given that BO has such a harmful influence on children's quality of life and acute M. pneumoniae bronchiolitis is not widely encountered, this study carries some significance. The utilization, time of initiation, and effects of glucocorticoids administration in the prevention of BO development warrant further investigation.
M. pneumoniae bronchiolitis can occur in children, especially in atopic individuals. The use, time of initiation, and effects of glucocorticoids administration in these patients for the prevention of BO require further investigation.
